Summit Tx Capital, L.P. Merck & Co., Inc. Transaction History
Summit Tx Capital, L.P.
- $2.42 Trillion
- Q3 2025
A detailed history of Summit Tx Capital, L.P. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 33,684 shares of MRK stock, worth $3.13 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
33,684
Previous 22,715
48.29%
Holding current value
$3.13 Million
Previous $1.8 Billion
57.23%
% of portfolio
0.12%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding MRK
# of Institutions
3,934Shares Held
1.9BCall Options Held
30.1MPut Options Held
27.7M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...